Allergy and Immunology · Charlotte, NC
NPI
1114952322
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2600 E 7th St, Unit A
Charlotte, NC, 28204
Phone (704) 372-7900
Groups this clinician bills Medicare through
Medicare paid, 2024
$530K
31,710 services
Medicare patients, 2024
624
Average age 73
Drug cost, 2024
$2.3M
1,805 prescriptions
Company payments, 2025
$18K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John G Norris was code 95165 (treatment - miscellaneous), 6,565 times for 365 patients. In total John G Norris billed 31,710 services in 40 codes, and Medicare paid $530K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 6,565 | 365 | $9.69 | $64K |
| J2357 Injection, omalizumab, 5 mg | Office | 5,956 | 13 | $29.55 | $176K |
| 95117 Treatment - Miscellaneous | Office | 4,556 | 285 | $7.79 | $35K |
| 95004 Test - Miscellaneous | Office | 3,276 | 50 | $2.59 | $8,480 |
| 95115 Treatment - Miscellaneous | Office | 2,215 | 145 | $6.39 | $14K |
| 95044 Test - Miscellaneous | Office | 660 | 12 | $3.28 | $2,166 |
| 95024 Test - Miscellaneous | Office | 489 | 37 | $5.76 | $2,818 |
| 96372 Injection Administration | Office | 324 | 35 | $9.83 | $3,185 |
| 95170 Treatment - Miscellaneous | Office | 318 | 33 | $7.20 | $2,290 |
| 95148 Treatment - Miscellaneous | Office | 255 | 27 | $63.71 | $16K |
| 99214 Office E&M - Established | Office | 189 | 129 | $84.18 | $16K |
| 95149 Treatment - Miscellaneous | Office | 136 | 15 | $84.50 | $11K |
| 99204 Office E&M - New | Office | 62 | 62 | $110.39 | $6,844 |
| 94375 Pulmonary Function Testing | Office | 51 | 42 | $25.58 | $1,305 |
| 99213 Office E&M - Established | Office | 47 | 44 | $63.74 | $2,996 |
By year: 2022 $647K for 31,033 services; 2023 $556K for 33,011 services; 2024 $530K for 31,710 services.
Medicare prescription drug claims, 2024
In 2024, the drug John G Norris prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 164 prescriptions and refills. In total John G Norris wrote 1,805 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 164 | 202 | 44 | $127K |
| Ipratropium Bromide Generic | 130 | 191 | 66 | $6,368 |
| Azelastine Hcl Generic | 128 | 221 | 57 | $4,389 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 102 | 105 | 54 | $1,952 |
| Montelukast Sodium Generic | 101 | 283 | 37 | $732 |
| Fluticasone Propionate Generic | 65 | 120 | 20 | $1,075 |
| Epinephrine Generic | 52 | 71 | 37 | $13K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 49 | 51 | 15 | $32K |
| Cuvitru Immun Glob G(Igg)/Gly/Iga Ov50 | 47 | 47 | Under 11 | $378K |
| Breo Ellipta Fluticasone/Vilanterol | 45 | 56 | Under 11 | $20K |
| Tezspire Tezepelumab-Ekko | 45 | 45 | Under 11 | $184K |
| Prednisone Generic | 42 | 53 | 30 | $126 |
| Levocetirizine Dihydrochloride Generic | 41 | 116 | 14 | $921 |
| Hyqvia Igg/Hyaluronidase,recombinant | 39 | 39 | Under 11 | $288K |
| Famotidine Generic | 39 | 70 | 14 | $325 |
Brand drugs: - claims; generic drugs: 1,003 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John G Norris $18K ($18K in general payments such as food, travel and fees) from 21 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $13K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 23 | $13K |
| Sanofi US Services Inc. SNY | 2 | $1,463 |
| AstraZeneca Pharmaceuticals LP AZN | 24 | $843 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $428 |
| Pfizer Inc. PFE | 46 | $393 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 18 | $368 |
| GlaxoSmithKline, LLC. GSK | 29 | $362 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $309 |
| Amgen Inc. AMGN | 10 | $308 |
| CSL Behring CSL.AX | 12 | $279 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.